AU2003293295A1 - Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders - Google Patents

Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Info

Publication number
AU2003293295A1
AU2003293295A1 AU2003293295A AU2003293295A AU2003293295A1 AU 2003293295 A1 AU2003293295 A1 AU 2003293295A1 AU 2003293295 A AU2003293295 A AU 2003293295A AU 2003293295 A AU2003293295 A AU 2003293295A AU 2003293295 A1 AU2003293295 A1 AU 2003293295A1
Authority
AU
Australia
Prior art keywords
treatment
propargyl alcohol
dermatological disorders
alcohol enantiomer
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003293295A
Other versions
AU2003293295A8 (en
Inventor
Jean-Claude Caron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0210412A external-priority patent/FR2843696A1/en
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of AU2003293295A8 publication Critical patent/AU2003293295A8/en
Publication of AU2003293295A1 publication Critical patent/AU2003293295A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2003293295A 2002-08-20 2003-08-04 Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders Abandoned AU2003293295A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0210412A FR2843696A1 (en) 2002-08-20 2002-08-20 Treating dermatological disorders, e.g. psoriasis or especially acne, using hydroxy-tetrahydronaphthyl-propynyl-benzoic acid derivative as pure S-(+)-enantiomer having low rate of clearance from the body
FR0210412 2002-08-20
US40572102P 2002-08-26 2002-08-26
US60/405,721 2002-08-26
PCT/EP2003/008624 WO2004032914A2 (en) 2002-08-20 2003-08-04 Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Publications (2)

Publication Number Publication Date
AU2003293295A8 AU2003293295A8 (en) 2004-05-04
AU2003293295A1 true AU2003293295A1 (en) 2004-05-04

Family

ID=32095126

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003293295A Abandoned AU2003293295A1 (en) 2002-08-20 2003-08-04 Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Country Status (2)

Country Link
AU (1) AU2003293295A1 (en)
WO (1) WO2004032914A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713635B1 (en) * 1993-12-15 1996-01-05 Cird Galderma New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses.

Also Published As

Publication number Publication date
WO2004032914A3 (en) 2004-06-10
AU2003293295A8 (en) 2004-05-04
WO2004032914A2 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003282679A1 (en) Hydroxypyrazoles for use against metabolic-related disorders
AU2003239474A1 (en) Device and method for the treatment of cardiac disorders
AU2003202237A1 (en) Method for altering the body temperature of a patient using a nebulized mist
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003298646A1 (en) Applicator for scalp medicine
AU2002248029A1 (en) Therapeutic lotion for dermatitis
SI1487828T1 (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2003293099A1 (en) Treatment of dna damage related disorders
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
AU2002368219A1 (en) Dermatological preparation for the treatment of skin lesions
ZA200405853B (en) Use of adapalene for the treatment of dermatological disorders
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2003251407A1 (en) Topical treatment for skin irritation
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
AU2003237460A1 (en) Combination treatments for purinoceptor-related disorders
AU2003209542A1 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase